Aficamten (5 - 20 mg)

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCMNCT04848506CytokineticsPhase 2, Phase 3Enrolling by invitation2029-03Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.